Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
  1. 4 Grant or award Director acquired 4,100 shares (grant or award)
  2. 4 Grant or award Director acquired 4,100 shares (grant or award)
  3. 4 Open-market sale Chief Operating Officer sold 9,617 shares at $31.62 ($304,090)
  4. 4 Grant or award General Counsel acquired 16,250 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 15,500 shares (grant or award)
  6. 4 Grant or award Chief Operating Officer acquired 31,250 shares (grant or award)
  7. 4 Grant or award President acquired 31,250 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 65,000 shares (grant or award)
  9. 4 Gift President gave 350,000 shares (gift)
  10. 4 Open-market sale Chief Operating Officer sold 34,822 shares at an average $41.48 ($1,444,369)
  11. 4 Open-market sale General Counsel sold 1,109 shares at an average $40.12 ($44,497)
  12. 4 Open-market sale Chief Financial Officer sold 1,106 shares at an average $40.12 ($44,376)
  13. 4 Open-market sale President sold 1,973 shares at an average $40.12 ($79,164)
  14. 4 Open-market sale Chief Operating Officer sold 12,678 shares at an average $40.12 ($508,684)
  15. 4 Open-market sale Chief Executive Officer sold 5,242 shares at an average $40.12 ($210,328)
  16. 4 Open-market sale Chief Operating Officer sold 47,500 shares at an average $35.35 ($1,678,914)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Director acquired 4,700 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market sale General Counsel sold 2,915 shares at an average $23.89 ($69,650)

Page 9 of 15 · 290 filings